Do selected drugs increase the risk of lupus? A matched case‐control study
Open accessThe DOI matches its Crossref record.
Abstract
WHAT IS ALREADY KNOWN ON THIS SUBJECT • Numerous previous case reports have suggested that lupus can be induced by a range of prescription medications. • Analytical studies quantifying risk of drug‐induced lupus are lacking. WHAT THIS STUDY ADDS • This was the first large study to quantify risk of lupus associated with carbamazepine, hydralazine, and other prescription medicines suspected of inducing the disease. • We confirmed some, but not all, associations that have been hypothesized in case reports. • This study provides evidence that increased risks may be causal given the lack of an increased risk observed with deliberately selected ‘comparison’ drugs. AIM: To investigate the association between risk of lupus and exposure to selected drugs implicated in risk of lupus in a number of case reports. METHODS: In this matched nested case‐control study we utilized primary care data from the UK General Practice Research Database recorded between 1987 and 2001. Cases with at least one medical code for systemic lupus erythematosus or drug‐induced lupus in their computerized records were matched to controls without a medical code for lupus or any other autoimmune disorder. Using conditional logistic regression we computed odds ratios (OR) and 95% confidence intervals (CI) for risk of lupus associated with exposure to selected drugs. RESULTS: There were 875 incident cases, of which 12% (n= 107) had evidence of a prescription for one or more of the suspected drugs, and 3632 matched controls. For some drugs, prescriptions were too uncommon to be able to estimate associated risk of lupus. Despite small numbers of exposed patients and low statistical precision we observed an increased risk of lupus for hydralazine (OR = 6.62, 95% CI 1.03, 42.74), minocycline (OR = 4.23, 95% CI 2.65, 6.75) and carbamazepine (OR = 1.88, 95% CI 1.09, 3.22). There was some indication that the effect of carbamazepine was restricted to women (P for interaction by gender = 0.047). CONCLUSION: This study shows that even those drugs suggested by case reports as causing lupus cannot all be clearly shown to be associated, even in a very large population‐based database. Our findings support causal relationships for carbamazepine, minocycline and possibly hydralazine. Overall, drugs do not seem to be a major cause of lupus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Minocycline for acne vulgaris: efficacy and safety
Garner, S. E., Eady, A., Bennett, C., Newton, J. N., Thomas, K., & Popescu, C. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002086.pub2 · Cited by 216
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2
McDonagh, E. M., Boukouvala, S., Aklillu, E., Hein, D. W., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000062 · Cited by 146
Challenges of Repurposing Tetracyclines for the Treatment of Alzheimer’s and Parkinson’s Disease
Markulin, I., Matasin, M., Turk, V. E., & Salković-Petrisic, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02457-2 · Cited by 36
“Drug-induced lupus among those with acne is more common among users of minocycline and in young females (Schoonen et al. 2010; Sturkenboom et al. 1999).”
BackgroundMedical Complications of Psychiatric Treatment
Lahijani, S. C., & Harris, K. A. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.03.008 · Cited by 8
Metadata
- Authors
- Schoonen, W. M., Thomas, S. L., Somers, E. C., Smeeth, L., Kim, J., Evans, S., & Hall, A. J.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2010-09-14
- Volume
- 70
- Issue
- 4
- Pages
- 588-596
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1679733705
- Cited by
- 66
- References
- 0
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do selected drugs increase the risk of lupus? A matched case‐control study. https://app.cochat.ai/papers/10.1111/j.1365-2125.2010.03733.x
- The paper
- Schoonen, W. M., Thomas, S. L., Somers, E. C., Smeeth, L., Kim, J., Evans, S., & Hall, A. J. (2010). Do selected drugs increase the risk of lupus? A matched case‐control study. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2010.03733.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.